Hyperlipoproteinemias
Information
- Disease name
- Hyperlipoproteinemias
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05425745 | Active, not recruiting | Phase 3 | Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. | July 25, 2022 | September 30, 2024 |
| NCT00477594 | Completed | Phase 2 | Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia | May 2007 | July 2011 |
| NCT00607373 | Completed | Phase 3 | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia | July 2007 | March 2009 |
| NCT00694109 | Completed | Phase 3 | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia | April 2008 | September 2014 |
| NCT04516291 | Completed | Phase 2 | A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) | September 28, 2020 | December 6, 2021 |
| NCT06163443 | Completed | N/A | Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. | March 2, 2022 | May 1, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006951